26 May 2013
Keywords: axcan, says, photofrin, excellent, new, use, pharma
Article | 01 July 2002
Axcan Pharma of Quebec has said that a Phase III trial of itsphotodynamic therapy for high grade dysplasia associated with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 July 2002
24 May 2013
© 2013 thepharmaletter.com